Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$173M |
| 2 |
Amcor
AMCR
|
+$138M |
| 3 |
Microsoft
MSFT
|
+$99.3M |
| 4 |
Amazon
AMZN
|
+$97.5M |
| 5 |
Intel
INTC
|
+$96.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$126M |
| 2 |
Alexandria Real Estate Equities
ARE
|
+$123M |
| 3 |
CHL
China Mobile Limited
CHL
|
+$58.6M |
| 4 |
IDTI
Integrated Device Technology I
IDTI
|
+$45.7M |
| 5 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$44.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.86% |
| 2 | Financials | 14.49% |
| 3 | Healthcare | 12.78% |
| 4 | Industrials | 10.5% |
| 5 | Consumer Discretionary | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
BCB Bancorp
BCBP
$155M
| $459K | ﹤0.01% |
33,112
+2,212
| +7% | +$28.4K |
|
2852
Bankwell Financial Group
BWFG
$533M
| $454K | ﹤0.01% |
15,790
+1,890
| +14% | +$55.4K |
|
2853
OptimizeRx
OPRX
$129M
| $454K | ﹤0.01% |
+27,978
| New | +$378K |
|
|
PVLA
2854
Palvella Therapeutics
PVLA
$2.19B
| $454K | ﹤0.01% |
1,207
-1,636
| -58% | -$488K |
|
2855
Aclaris Therapeutics
ACRS
$867M
| $453K | ﹤0.01% |
206,589
+32,759
| +19% | +$179K |
|
2856
Mammoth Energy Services
TUSK
$162M
| $453K | ﹤0.01% |
65,722
-59,855
| -48% | -$761K |
|
2857
Pure Cycle
PCYO
$270M
| $450K | ﹤0.01% |
42,440
| – | – |
|
|
PFBI
2858
DELISTED
Premier Financial Bancorp
PFBI
| $449K | ﹤0.01% |
29,906
+3,825
| +15% | +$61.5K |
|
2859
PCB Bancorp
PCB
$387M
| $448K | ﹤0.01% |
26,244
+1,426
| +6% | +$24.9K |
|
2860
LifeVantage
LFVN
$84.3M
| $447K | ﹤0.01% |
+34,397
| New | +$409K |
|
|
SLCT
2861
DELISTED
Select Bancorp, Inc.
SLCT
| $447K | ﹤0.01% |
39,034
+3,974
| +11% | +$46K |
|
2862
Alpha and Omega Semiconductor
AOSL
$1.03B
| $446K | ﹤0.01% |
47,743
+2,347
| +5% | +$24.5K |
|
|
MSON
2863
DELISTED
Misonix Inc
MSON
| $445K | ﹤0.01% |
+17,499
| New | +$362K |
|
2864
Ocular Therapeutix
OCUL
$2.03B
| $443K | ﹤0.01% |
100,658
+27,585
| +38% | +$102K |
|
2865
Fidelity D&D Bancorp
FDBC
$310M
| $442K | ﹤0.01% |
6,570
| – | – |
|
2866
Protagonist Therapeutics
PTGX
$9.71B
| $442K | ﹤0.01% |
+36,469
| New | +$403K |
|
2867
DHI Group
DHX
$158M
| $441K | ﹤0.01% |
123,384
+106,368
| +625% | +$369K |
|
|
LAND
2868
Gladstone Land Corp
LAND
$351M
| $440K | ﹤0.01% |
38,085
+4,207
| +12% | +$52K |
|
2869
BGSF Inc
BGSF
$59.3M
| $438K | ﹤0.01% |
23,177
+3,249
| +16% | +$65.8K |
|
|
BOCH
2870
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $438K | ﹤0.01% |
40,924
+5,696
| +16% | +$60.6K |
|
2871
Superior Group of Companies
SGC
$206M
| $434K | ﹤0.01% |
25,305
+4,848
| +24% | +$82.8K |
|
2872
KVH Industries
KVHI
$148M
| $431K | ﹤0.01% |
39,626
| – | – |
|
2873
Rocky Brands
RCKY
$364M
| $431K | ﹤0.01% |
15,771
| – | – |
|
2874
Riverview Bancorp
RVSB
$107M
| $431K | ﹤0.01% |
50,375
+3,085
| +7% | +$24K |
|
|
EVBN
2875
DELISTED
Evans Bancorp Inc
EVBN
| $431K | ﹤0.01% |
11,412
+700
| +7% | +$25.1K |
|
Similar funds
Charles Schwab's Q2 2019 Portfolio in Review
As of Q2 2019, Charles Schwab held 3,341 positions worth $164B, up 5.3% from $156B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Charles Schwab's Q2 2019 filing shows 147 new, 2,302 increased, 628 reduced and 129 closed positions. Its largest new stake was Dow Inc: 3,280,629 shares worth $162M. The largest sale was DuPont de Nemours, an estimated $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2019 buy was Dow Inc: 3,280,629 shares worth $162M.
- Charles Schwab added most to Microsoft in Q2 2019, an estimated $99.3M increase.
- Charles Schwab's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $126M.
- Charles Schwab fully exited China Mobile Limited in Q2 2019, selling an estimated $58.6M.
- Charles Schwab's ten largest holdings make up 15% of its $164B portfolio in Q2 2019.
- Charles Schwab opened 147 new positions and closed 129 in Q2 2019.
- Charles Schwab's portfolio value rose 5.3% quarter-over-quarter to $164B.
Based on Charles Schwab's 13F filing for Q2 2019, filed 9 Aug 2019.